Physician profile
Jonathan M Treece
NPI 1780978700
$402.93
in general payments reported to CMS, 2019-2025
8 companies · $42.43 in 2025
The $42.43 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.09 · 2020: $145 · 2021: $55.19 · 2022: $29.95 · 2023: $60.36 · 2024: $36.00 · 2025: $42.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $170.99 | 2020-2023 | Wegovy |
| Abbvie INC. | $51.18 | 2021-2022 | |
| Allergan, INC. | $47.77 | 2019-2020 | |
| Abbott Laboratories | $38.63 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $30.56 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.27 | 2025 | |
| Amarin Pharma, INC. | $20.47 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Treece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.